Retroviruses
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Subviral Agents
Retrovirus Life Cycles
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 8, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Clínico Universitario de Valencia, Valencia, España.
No abstract available in PubMed .